Alcon Rolls Out UNITY CS Platform in Canada

Alcon has launched the UNITY Cataract System (CS), its next-generation standalone cataract surgical platform, in the Great White North.

The Canadian availability of UNITY CS builds on growing global momentum for the UNITY platform, which has already supported more than 285,000 procedures globally across 1,350 systems worldwide, according to the company. UNITY CS is Alcon’s standalone cataract surgical system and part of the platform, which also includes UNITY Vitreoretinal Cataract System (VCS). While UNITY VCS supports both vitreoretinal and cataract procedures within one integrated platform, UNITY CS is dedicated specifically to cataract surgery.

This launch is part of a broader wave of innovation from Alcon this year, with multiple new product introductions across surgical and therapeutic categories—including UNITY VCS, PanOptix Pro, and the Valeda photobiomodulation (PBM) device for treating early and intermediate dry age-related macular degeneration (AMD)—reflecting the company’s mission to advance eye care through an expanding innovation pipeline.

“[This]marks an exciting milestone for Alcon as we continue advancing the next generation of surgical innovation in Canada,” said Mark Newson, country manager and head of Surgical, Alcon Canada. “With UNITY CS, we are bringing forward technology designed to help surgeons and surgical teams operate with greater efficiency, consistency, and confidence in cataract surgery while supporting a smoother workflow in the operating room.”

Designed to support greater surgical efficiency and consistency, UNITY CS leverages a novel phacoemulsification modality engineered to deliver up to two times faster nucleus removal^ with 40% less energy** into the eye. The platform also features a first-of-its-kind phaco handpiece that estimates temperature at the incision site.^1,2,3

The UNITY VCS/CS system has also received international recognition for innovation in surgical technology. Earlier this year, Alcon was named the Overall Winner in the 2026 BIG Innovation Awards for UNITY VCS, recognized for transforming ophthalmic surgical workflows through innovation and measurable impact. More recently, UNITY VCS received a Silver Edison Award in the Surgical Robotics & Precision Therapy category, recognizing the platform’s advancements in surgical precision and workflow integration.

UNITY VCS and UNITY CS are among the newest innovations from the Alcon Vision Suite, a portfolio of products designed to help eye care professionals increase clinic and operating room efficiency.

“Together, these innovations reflect Alcon’s continued focus on advancing the future of ophthalmic care in Canada,” Newson added. “This is just the beginning as we continue to build on the UNITY platform to deliver a new standard of connected surgical innovation for Canadian ophthalmology.”

With a heritage spanning more than 75 years, Alcon claims to offer the broadest portfolio of products to enhance sight. Each year, Its Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries living with conditions like cataracts, glaucoma, retinal diseases, and refractive errors. The company’s more than 25,000 associates enhance the quality of life through products, partnerships with eye care professionals, and programs that advance access to quality eye care.

UNITY Vitreoretinal Cataract System (VCS) is Alcon’s most advanced surgical platform designed to support both vitreoretinal and cataract procedures within one integrated platform, and UNITY Cataract System (CS) is a standalone cataract system. The UNITY platform delivers surgical care for patients with vision-threatening eye conditions by helping surgeons operate with greater consistency, stability, and efficiencies over Alcon’s current systems, the CONSTELLATION Vision System for vitreoretinal and combined procedures,††^,†^,‡ and CENTURION Vision System with ACTIVE SENTRY for cataract surgery.***^,4

UNITY VCS and UNITY CS leverage a novel phacoemulsification modality to deliver up to two times faster nucleus removal^ with 40% less energy* into the eye,² and a first-of-its-kind phaco handpiece that estimates temperature at the incision site.³

^ 2x faster nucleus removal than OZIL Torsional phaco
* Per reduction in cumulative dissipated energy (CDE)
** Based on N=10 HPs, Artificial cataract lens IOP 55 mmHg vacuum of 450 mmHg
*** Based on bench data. Reduction in surge is correlated to less change in anterior chamber depth.
† For posterior segment surgeries/posterior cassette pack.
†† (P<0.001).
‡ ~1 minute faster.

References
¹ Alcon Data on File, 2024 – REF-24379.
² Alcon Data on File, 2024 – REF-24644.
³ Unity VCS User Manual 2024 – REF-24980.
⁴ lcon Data on File, 2024 – REF-25374.